Charles T. Roberts

Charles T. Roberts

Auto-generated profile, based on publicly available information

Charles T. Roberts

Division of Metabolic Health and Disease, Oregon National Primate Research Center (ONPRC)

Research Focus & Metrics

Academic Career Length

72Years (1955-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Cancer Letters
Verified
Journal Article
Open access
DLDerek LeRoith
Derek LeRoith
CRCharles T. Roberts
Charles T. Roberts
The insulin-like growth factor (IGF) family of ligands, binding proteins and receptors is an important growth factor system involved in both the development of the organism and the maintenance of normal function of many cells of the body. The system also has powerful anti-apoptotic effects. More recently, evidence has accrued to demonstrate that the IGFs play an important role in cancer. Individuals with serum IGF-II levels in the upper quartile of the normal range (and IGF binding protein-3 levels in the lower quartiles) have a relative risk for developing breast, prostate, colon and lung cancer. IGF-II is commonly expressed by tumor cells and may act as an autocrine growth factor; occasionally even reaching target tissues and causing tumor-induced hypoglycemia. The IGF-I receptor is commonly (though not always) overexpressed in many cancers, and many recent studies have identified new signaling pathways emanating from the IGF-I receptor that affect cancer cell proliferation, adhesion, migration and cell death; functions that are critical for cancer cell survival and metastases. In this review, many aspects of the IGF system and its relationship to cancer will be discussed.

19 January 2015 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
OVOleg Varlamov
Oleg Varlamov
CBCynthia L. Bethea
Cynthia L. Bethea
CRCharles T. Roberts
Charles T. Roberts
Energy metabolism in humans is tuned to distinct sex-specific functions that potentially reflect the unique requirements in females for gestation and lactation, whereas male metabolism may represent a default state. These differences are the consequence of the action of sex chromosomes and sex-specific hormones, including estrogens and progesterone in females and androgens in males. In humans, sex-specific specialization is associated with distinct body-fat distribution and energy substrate-utilization patterns; i.e., females store more lipids and have higher whole-body insulin sensitivity than males, while males tend to oxidize more lipids than females. These patterns are influenced by the menstrual phase in females, and by nutritional status and exercise intensity in both sexes. This minireview focuses on sex-specific mechanisms in lipid and glucose metabolism and their regulation by sex hormones, with a primary emphasis on studies in humans and the most relevant pre-clinical model of human physiology, non-human primates.

1 February 1992 in Neuroscience
Verified
Journal Article
Closed access
CBC. Bondy
C. Bondy
HWH. Werner
H. Werner
CRC.T. Roberts
C.T. Roberts
DLD. LeRoith
D. LeRoith

1 September 1990 in Molecular Endocrinology
Verified
Journal Article
Closed access
CBCarolyn A. Bondy
Carolyn A. Bondy
HWHaim Werner
Haim Werner
CRCharles T. Roberts
Charles T. Roberts
DLDerek LeRoith
Derek LeRoith
To investigate the potential role(s) of the insulin-like growth factors (IGFs) in embryogenesis, we have used in situ hybridization histochemistry to localize mRNAs for IGF-I, IGF-II, and the type I IGF receptor during an early period in rat embryonic development (embryonic days 14 and 15). IGF-I and IGF-II mRNAs were found in distinctly different patterns of cellular distribution. IGF-I mRNA was particularly abundant in undifferentiated mesenchymal tissue in the vicinity of sprouting nerves and spinal ganglia, and in circumscribed regions of the developing face that corresponded to the target zones of the trigeminal nerve. IGF-I mRNA was also found in aggregations of mesenchyme surrounding, but not in developing muscle and cartilage. IGF-I mRNA was selectively concentrated in areas of active tissue remodeling, such as the cardiac outflow tract, and was undetectable in liver, pituitary, and nervous system at this early stage of organogenesis. IGF-II mRNA was abundant in developing muscle, cartilage, and vascular tissue, and in the embryonic liver and pituitary. IGF-II mRNA was also conspicuous in areas of vascular interface with the brain, such as the choroid plexus and the organum vasculosum of the lamina terminalis. Messenger RNA for the type I IGF receptor was widely distributed in embryonic tissues, but the highest level were seen in the ventral floorplate of the hindbrain, where specialized neuroepithelial cells act as guides for axonal targeting. In conclusion, the different cellular patterns of expression of genes for IGF-I and IGF-II indicate that these two IGFs are differently regulated and, thus, may have significantly different roles in the process of embryonic development. Furthermore, the early and widespread expression of the type-I IGF receptor gene, in contrast to the relatively limited and localized pattern of IGF-I gene expression, is consistent with the view that this receptor may mediate the effects of IGF-II as well as IGF-I during embryogenesis.

25 November 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HKHo-Seong Kim
Ho-Seong Kim
SNSrinivasa R. Nagalla
Srinivasa R. Nagalla
YOYoungman Oh
Youngman Oh
EWElizabeth Wilson
Elizabeth Wilson
CRCharles T. Roberts
Charles T. Roberts
RRRon G. Rosenfeld
Ron G. Rosenfeld
The insulin-like growth factor (IGF) binding proteins (IGFBPs) modulate the actions of the insulin-like growth factors in endocrine, paracrine, and autocrine settings. Additionally, some IGFBPs appear to exhibit biological effects that are IGF independent. The six high-affinity IGFBPs that have been characterized to date exhibit 40–60% amino acid sequence identity overall, with the most conserved sequences in their NH2and COOH termini. We have recently demonstrated that the product of the mac25/IGFBP-7 gene, which shows significant conservation in the NH2terminus, including an “IGFBP motif” (GCGCCXXC), exhibits low-affinity IGF binding. The closely related mammalian genes connective tissue growth factor (CTGF) gene,nov, andcyr61encode secreted proteins that also contain the conserved sequences and IGFBP motifs in their NH2termini. To ascertain if these genes, along with mac25/IGFBP-7, encode a family of low-affinity IGFBPs, we assessed the IGF binding characteristics of recombinant human CTGF (rhCTGF). The ability of baculovirus-synthesized rhCTGF to bind IGFs was demonstrated by Western ligand blotting, affinity cross-linking, and competitive affinity binding assays using125I-labeled IGF-I or IGF-II and unlabeled IGFs. CTGF, like mac25/IGFBP-7, specifically binds IGFs, although with relatively low affinity. On the basis of these data, we propose that CTGF represents another member of the IGFBP family (IGFBP-8) and that the CTGF gene, mac25/IGFBP-7,nov, andcyr61are members of a family of low-affinity IGFBP genes. These genes, along with those encoding the high-affinity IGFBPs 1–6, together constitute an IGFBP superfamily whose products function in IGF-dependent or IGF-independent modes to regulate normal and neoplastic cell growth.

2 January 2009 in Journal of Proteome Research
Verified
Journal Article
Closed access
PRPaturi V. Rao
Paturi V. Rao
ARAshok P. Reddy
Ashok P. Reddy
XLXinfang Lu
Xinfang Lu
SDSurendra Dasari
Surendra Dasari
AKAdiraju Krishnaprasad
Adiraju Krishnaprasad
SNSrinivasa R. Nagalla
Srinivasa R. Nagalla